The shining momentum for ContextLogic (NASDAQ:WISH) came and left in a hurry in June. Meme traders, where traders depicted stock buys with an image and a few words, lifted WISH stock. After ContextLogic posted results on August 12, any positive momentum all but evaporated. That is bad news for
Copart (NASDAQ:CPRT) had its price target hoisted by Truist from $145.00 to $160.00 in a research report sent to investors on Friday, The Fly reports. The brokerage currently has a buy rating on the business services provider's stock.
Several other research firms have also issued reports
Thermo Fisher Scientific (NYSE:TMO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday.
According to Zacks, “Thermo Fisher ended the first quarter on a promising note with adjusted earnings and revenues surpassing the consensus mark. We are encouraged by the company’s solid international performance on strong growth in the emerging markets of China, South Korea and India. Also, a series of product launches along with major progress in precision medicine initiatives aided Thermo Fisher’s....More>>>
Legendary investor Bill Miller is the former chairman and chief investment officer of Legg Mason Capital Management. He has been named fund manager of the decade by Morningstar and ranked as the top 30 most influential people in investing by SmartMoney. Below is an edited summary of his interview with The Investor’s Podcast where he talks about determining the intrinsic value of various companies like Amazon, Apple, and Tesla Motors.
Listen to this interview in your car by subscribing to the show on iTunes or Stitcher.
Preston Pysh: How does your approach differ from....More>>>
Steve Wynn agreed to give up control over his ex-wife’s shares of Wynn Resorts Ltd., potentially ending their six-year legal battle days after he resigned from the casino company following accusations of sexual harassment.
If a judge approves, Steve Wynn’s voting power will shrink to 11.8 percent of the shares, with Elaine Wynn able to determine what to do with her 9.4 percent stake. That may leave Wynn Resorts more vulnerable to activists or potential acquirers.
The company said in a filing Friday that Steve Wynn has no immediate plans to sell his shares and would....More>>>
Related GWPH Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High GW Pharma Oncology Is Potential Underrated (Seeking Alpha)
Related ZYNE Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Benzinga's Top Upgrades, Downgrades For February 24, 2017 Zynerba Pharmaceuticals Undervalued Compared To GW Pharmaceuticals....More>>>
That didn’t take long. After a one-week absence as the Dow Jones Industrial Average (DJIA) index’s best performing stock, Boeing Co. (NYSE: BA) has reclaimed its top ranking last week with a gain of nearly 9%. For the first two weeks of 2018, Boeing shares have added 14%.
The second-best performer among the Dow 30 so far this year is Caterpillar Inc. (NYSE: CAT), up just over 8%, and it was the Dow’s second-best performer for all of 2017. General Electric Co. (NYSE: GE) held the top spot in the first week of the yearbut slid to third-best last week with two-week total....More>>>
Shares of Switch, Inc. (NYSE:SWCH) have been given a consensus recommendation of "Buy" by the twelve research firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, nine have given a buy recommendation and on
Following in the wake of fellow dry bulk shipping stocks Diana Shipping (NYSE:DSX) last week and Safe Bulkers (NYSE:SB) Monday morning, Seanergy Maritime Holdings (NASDAQ:SHIP) and Castor Maritime (NASDAQ:CTRM) surged ahead to close the trading session up 12% and 13%.
We're entering the home stretch of the year. Last month, I pointed out that the fall season is one of the best times for dividend hikes. And it will be interesting to see which companies announce dividend hikes in this challenging environment.
HOOKIPA (HOOK Quick QuoteHOOK ) announced that it has entered into a clinical collaboration and supply agreement with Merck (MRK Quick QuoteMRK ) to evaluate the former’s novel arenaviral program, HB-200, in combination with the latter’s PD-L1 inhibitor Keytruda as a fi